Study of Berberine Hydrochloride in Prevention of Colorectal Adenomas Recurrence

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

1,108

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 29, 2018

Study Completion Date

December 29, 2018

Conditions
Colorectal Adenoma
Interventions
DRUG

Berberine hydrochloride

supplement of Berberine hydrochloride 0.3g two times per day for 2-3 years

DRUG

placebo

supplement of placebo two times per day for 2-3 years

Trial Locations (7)

200001

Division of Gastroenterology and Hepatology, Ren-Ji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai Institute of Digestive Disease; Key Laboratory of Gastroenterology & Hepatology, Ministry of Health, Shanghai

Unknown

Department of Gastroenterology, the Seventh Medical Center of PLA General Hospital, Beijing

Department of Gastroenterology, Zhongshan Hospital, Xiamen University, Xiamen

Department of Gastroenterology, Nanfang Hospital, Southern Medical Univerisity, Guangdong

Division of Gastroenterology and Hepatology, The Affiliated DrumTower of Nanjing University Medical School, Nanjing

Department of Gastroenterology, the Shanghai Tenth People's Hospital, Tongji University, Shanghai

Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT02226185 - Study of Berberine Hydrochloride in Prevention of Colorectal Adenomas Recurrence | Biotech Hunter | Biotech Hunter